We are live on
!
Find out more
FA
Fagan Associates Portfolio holdings
AUM
$813M
1-Year Est. Return
37.92%
This Fund
S&P 500
This Quarter
Est. Return
+9.57%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+585.67%
AUM
$412M
AUM Growth
+$10.2M
(+2.5%)
Cap. Flow
-$19.9M
Cap. Flow
% of AUM
-4.83%
Top 10 Holdings %
Top 10 Hldgs %
44.76%
Holding
128
New
6
Increased
36
Reduced
52
Closed
16
Avg Time Held
17.4
quarters
Top 10 Avg Time Held
13.2
quarters
Top 20 Avg Time Held
18.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crane NXT
CXT
|
+$3.64M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$2.76M |
| 3 |
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
|
+$1.51M |
| 4 |
UnitedHealth
UNH
|
+$1.31M |
| 5 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$1.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$9.82M |
| 2 |
Target
TGT
|
+$5.67M |
| 3 |
GlobalFoundries
GFS
|
+$3.61M |
| 4 |
Pfizer
PFE
|
+$2.5M |
| 5 |
VanEck Fallen Angel High Yield Bond ETF
ANGL
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.46% |
| 2 | Technology | 24.54% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 9.85% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
PepsiCo
PEP
$172B
| $631K | 0.15% |
3,408
-13
| -0.4% | -$2.43K |
2019 Q1
17 quarters
|
|
77
Vanguard Total International Bond ETF
BNDX
$82.5B
| $626K | 0.15% |
12,812
-113
| -0.9% | -$5.51K |
2014 Q3
35 quarters
|
|
78
Medical Properties Trust
MPT
$1.88B
| $599K | 0.15% |
64,685
-588
| -0.9% | -$4.97K |
2021 Q4
6 quarters
|
|
79
Invesco Taxable Municipal Bond ETF
BAB
$838M
| $582K | 0.14% |
21,923
-495
| -2% | -$13.2K |
2021 Q4
6 quarters
|
|
80
Canadian National Railway
CNI
$71.2B
| $554K | 0.13% |
4,575
-10
| -0.2% | -$1.19K |
2014 Q1
37 quarters
|
|
81
Coca-Cola
KO
$379B
| $519K | 0.13% |
8,622
| – | – |
2020 Q2
12 quarters
|
|
82
GE Aerospace
GE
$320B
| $492K | 0.12% |
5,610
| – | – |
2021 Q4
6 quarters
|
|
83
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.7B
| $456K | 0.11% |
952
| – | – |
2014 Q1
37 quarters
|
|
84
Edwards Lifesciences
EW
$49.1B
| $446K | 0.11% |
4,725
| – | – |
2018 Q2
20 quarters
|
|
85
Gilead Sciences
GILD
$187B
| $443K | 0.11% |
5,745
+600
| +12% | +$47.9K |
2022 Q4
2 quarters
|
|
86
CSX Corp
CSX
$87.5B
| $414K | 0.1% |
12,131
| – | – |
2021 Q1
9 quarters
|
|
87
First Trust Smith Unconstrained Bond ETF
UCON
$3.2B
| $409K | 0.1% |
16,940
+1,150
| +7% | +$28K |
2023 Q1
1 quarter
|
|
88
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22B
| $399K | 0.1% |
4,698
-80
| -2% | -$6.13K |
2019 Q3
15 quarters
|
|
89
Procter & Gamble
PG
$351B
| $378K | 0.09% |
2,488
| – | – |
2019 Q3
15 quarters
|
|
90
Charles Schwab
SCHW
$167B
| $347K | 0.08% |
6,118
+750
| +14% | +$39.3K |
2022 Q3
3 quarters
|
|
91
iShares Core S&P 500 ETF
IVV
$899B
| $342K | 0.08% |
767
| – | – |
2022 Q1
5 quarters
|
|
92
Caterpillar
CAT
$368B
| $322K | 0.08% |
1,310
| – | – |
2022 Q4
2 quarters
|
|
93
McDonald's
MCD
$166B
| $321K | 0.08% |
1,077
| – | – |
2014 Q1
37 quarters
|
|
94
Moderna
MRNA
$89.8B
| $315K | 0.08% |
2,595
+170
| +7% | +$22.7K |
2023 Q1
1 quarter
|
|
95
Deere & Co
DE
$167B
| $315K | 0.08% |
777
| – | – |
2020 Q4
10 quarters
|
|
96
Bristol-Myers Squibb
BMY
$121B
| $306K | 0.07% |
4,789
-75
| -2% | -$5.03K |
2019 Q3
15 quarters
|
|
97
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $302K | 0.07% |
1,371
-397
| -22% | -$82.8K |
2021 Q2
8 quarters
|
|
98
American Express
AXP
$208B
| $289K | 0.07% |
1,660
-315
| -16% | -$50.8K |
2021 Q1
9 quarters
|
|
99
Southern Company
SO
$99.1B
| $282K | 0.07% |
4,011
| – | – |
2020 Q4
10 quarters
|
|
100
Merck
MRK
$359B
| $279K | 0.07% |
2,420
+68
| +3% | +$7.72K |
2022 Q2
4 quarters
|
|
Similar funds
CFO
REA
TLP
DMC
BPIM
GCM
KCPG
WAM
Fagan Associates's Q2 2023 Portfolio in Review
As of Q2 2023, Fagan Associates held 128 positions worth $412M, up 2.5% from $402M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Fagan Associates withdrew a net $19.9M in Q2 2023, closing 16 positions and reducing 52 holdings. Its most notable exit was Qualcomm, an estimated $9.82M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Fagan Associates opened a new position in Crane NXT worth $4.04M.
- Fagan Associates's largest Q2 2023 buy was Crane NXT: 71,631 shares worth $4.04M.
- Fagan Associates added most to UnitedHealth in Q2 2023, an estimated $1.31M increase.
- Fagan Associates's biggest Q2 2023 reduction was Alphabet (Google) Class A, cutting an estimated $279K.
- Fagan Associates fully exited Qualcomm in Q2 2023, selling an estimated $9.82M.
- Fagan Associates's ten largest holdings make up 45% of its $412M portfolio in Q2 2023.
- Fagan Associates opened 6 new positions and closed 16 in Q2 2023.
- Fagan Associates's portfolio value rose 2.5% quarter-over-quarter to $412M.
Based on Fagan Associates's 13F filing for Q2 2023, filed 8 Aug 2023.